The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Travis (2025)
E-cigarette Retail Outlets in Mexico: A Country That Bans the Sale
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Zepeta Hernández (2025)
The Lifetime Health and Economic Burden of Smokeless Tobacco use in Bangladesh, India, and Pakistan: Results From ASTRAMOD
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Coyle (2025)
The Impact of Three Alternate Nicotine-Delivery Products on Combusted Cigarette Use: A Randomized Controlled Trial
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Piper (2025)
A Content Analysis of Nicotine Descriptors on the Front of Vape Packaging in the United Kingdom
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ford (2025)
A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Azzopardi (2022)
A Novel Nicotine Sublingual Tablet which Mimics Cigarette Smoking Pharamceuticals
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
McCarty (2015)
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®)
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Dautzenberg et al (2007)
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Gisleskog et al (2021)
Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: A review
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Le Houezec (2003)